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When is forgetting not forgetting? A discursive analysis of 
differences in forgetting talk between high and low adherers to 
nebulizer treatments in adults with cystic fibrosis
Abstract
Forgetting is often cited as a reason why people struggle to adhere to treatments for chronic 
conditions. Interventions have tried to improve forgetting behavior using reminders. We used 
a discursive psychological approach to explore differences in how high and low adherers 
constructed forgetting their nebulizer treatments for cystic fibrosis. Interviews were 
conducted with 18 adults from a cystic fibrosis center in the United Kingdom. High adherers 
constructed forgetting treatments as occasional lapses in automaticity and temporary lapses in 
memory that they found easy to repair. Low adherers utilized forgetting to normalize more 
consistent non-adherence to treatments. However, it is important to contextualize forgetting 
as a discursive resource that helped these participants to negotiate moral discourses around 
adherence to treatment that reminder interventions cannot address; we therefore recommend a 
more behavioral, patient-focused, theory-driven approach to intervention development.
Introduction
Adherence is defined as the extent to which the patients behavior matches agreed 
recommendations from the prescriber (Horne et al., 2005, p.33), and is recognized as a 
complex behavior that varies between individuals (Kahwati et al., 2016). Low adherence to 
treatment is a global health problem that has been linked to poorer outcomes such as 
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increased morbidity, mortality and other costs across a range of clinical conditions (Conn & 
Ruppar, 2017), including chronic health conditions such as cystic fibrosis. 
Adherence to nebulizer treatments in cystic fibrosis
Cystic fibrosis is a medical condition affecting around 0.7 people in every 10,000 people in 
the United States and Europe (Farrell, 2008), including around 10,400 people in the United 
Kingdom (Cystic Fibrosis Trust, 2012). It is a life-limiting disease and although life 
expectancy rates have increased, median survival is projected to be 47 years (Cystic Fibrosis 
Trust, 2018). Cystic fibrosis is a genetic condition characterized by a build-up of sticky 
mucus that predominantly affects the lungs, but also the digestive system and other organs. It 
is typified by repeated infections of the lower respiratory tract that cause difficulty breathing, 
leading to lung damage and ultimately death from respiratory failure. 
Medications to improve respiratory function, including mucolytics and antibiotics delivered 
by nebulizers, have been shown to be effective in reducing exacerbations and preserving lung 
function (Briesacher et al., 2011; Eakin, Bilderback, Boyle, Mogayzel, & Riekert, 2011; 
Ryan, Singh, & Dwan, 2011; Smith, Rowbotham, & Regan, 2018; Yang & Montgomery, 
2018). However, consistent with other chronic conditions, adherence to treatment is low, with 
the median rate of nebulizer adherence of adults in clinical practice ranging from 31-53% for 
inhaled antibiotics and 53-79% for inhaled mucolytics (Eakin et al., 2011). 
Research has identified a number of barriers and facilitators to adherence in the adult and 
pediatric population with cystic fibrosis, including to nebulizer treatments. Commonly 
reported barriers to adherence include: treatment burden, practical issues such as collecting 
prescriptions and lack of time to do treatments; competing goals including a desire to be 
'normal'; lack of perceived treatment effectiveness and understanding of treatment 
recommendations; negative feelings about nebulizers or more general anxiety and depression; 
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social and work demands; personal characteristics; current state of health; and forgetting 
(Abbott, Havermans, & Hart, 2009; Arden, Drabble, OCathain, Hutchings, & Wildman, 
2019; Arias-llorente, García, & Martín, 2011; George et al., 2010; Hogan, Bonney, Brien, 
Karamy, & Aslani, 2015; Horky, Sherman, & Polvinen, 2014; Lask, 1994; Macdonald et al., 
2016; Plummer, Costall, & Torry, 2008; Sawicki, Heller, Demars, & Robinson, 2014).
Reported facilitators of adherence include: accessibility and portability of treatment; 
adherence as part of an individuals identity and maintaining control; awareness of the 
importance of treatment; social support; and having a routine (Arden et al., 2019; Arias-
llorente et al., 2011; Foster et al., 2001; George et al., 2010; Hogan et al., 2015; Hoo, Boote, 
Wildman, Campbell, & Gardner, 2017; Horky et al., 2014; Plummer et al., 2008; Sawicki et 
al., 2014).
Forgetting to take medication has been identified as a major barrier for both the adult and 
pediatric population with cystic fibrosis (Abbott et al., 2009; Bregnballe, Schiøtz, Boisen, 
Pressler, & Thastum, 2011; Dziuban, Saab-Abazeed, Chaudhry, Streetman, & Nasr, 2010; 
George et al., 2010; Horky et al., 2014; Modi & Quittner, 2006; Owen & John, 2016; 
Plummer et al., 2008; Sawicki et al., 2014). For example, Sawicki and colleagues (2014) 
reported that 29% of adolescent participants  cited forgetting as the reason for not 
undertaking their nebulizer treatments. However, two smaller studies in adult patients have 
started to question the role of forgetting in adherence behavior, suggesting that nebulizer 
treatments in adults may be so routinized that forgetting is not an issue (Hogan et al., 2015). 
In a study of the differences in barriers and facilitators to adherence of nebulizer treatments 
between high and low adherers, Arden et al. (2019) found that forgetting was given as a 
reason for non-adherence by adults regardless of whether they had high or low adherence, 
suggesting that addressing forgetting may not be a useful way to improve adherence. 
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Moral issues in non-adherent behavior
In the adherence literature, non-adherence has been categorized as intentional or 
unintentional (Horne et al., 2005). Intentional non-adherence is when people make a 
conscious, deliberate decision not to adhere to their treatment either some or all of the time 
and is indicative of low motivation to adhere. Unintentional non-adherence is where people 
miss treatments inadvertently for reasons out of their control (Gadkari & McHorney, 2012) 
even though they are motivated to adhere.  
The term adherence tries to move away from normative judgements about good (compliant) 
and bad (non-compliant) behavior, to emphasize the patients right to choose whether to 
follow the prescribers recommendations (Horne et al., 2005). However, there is an 
underlying assumption that the patient should follow adherence advice because it is rational 
to maintain good health, thus creating a normative expectation that patients will adhere to 
treatment unless there is a good reason not to. Not following this assumption means the 
patients credibility as a good person who is morally adequate (Steele, 1988), and their 
identity as a good patient, may be questioned. In a study of self-management of long-term 
conditions (stroke, diabetes and colorectal cancer), Ellis et al. (2017) defined the good self-
manager as someone who takes treatments within the medical parameters set by the health 
service. They argued that this definition assumes that the patient chooses to adhere to 
treatment, and has the ability to control any behavioral change in order to adhere. However, 
this fails to recognize that taking recommended treatments may not be what individuals want 
because patients can make rational decisions to not adhere that make sense to them (Donovan 
& Blake, 1992). Thus, McHorney argued that non-adherence means that issues important to 
the patient were not addressed (2016, p.473). Furthermore, behavioral change may be 
difficult for individuals. 
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Research suggests that people can be unaware of their reasons for non-adherent behavior 
(e.g., Wegner, 2004). Navigating assumptions around expectations that patients will do their 
treatments creates a moral dilemma for the patient: how do they maintain their identity as a 
good patient if they do not adhere to treatment, even if it is based on what the patient 
perceives as a perfectly rational decision or something outside of their ability to change? 
With regards to forgetting as a reason for non-adherence, forgetting is commonly understood 
as a lapse in memory that happens occasionally unless there is damage to the memory 
through accident or ill health (Spear, 2014), and is thus unintentional. However, in a survey 
of adherence behavior in 24,017 adults with chronic conditions such as asthma or diabetes, 
Gadkari & McHorney (2012) questioned if forgetting was really unintentional. They found 
that forgetting, along with other unintentional non-adherence behaviors such as carelessness, 
mediated the relationship between medication beliefs and intentional non-adherence. They 
suggested that forgetting might instead predict future intentional non-adherence to treatment. 
A discursive psychological approach
A discursive psychological approach focuses on language as action, considering how people 
utilize language during interactions to construct particular versions or realities, and the 
functions these constructions serve (Potter & Wetherell, 1987). Language is thus a tool to 
get things done (Potter & Wetherell, 1987, p.87); for example, to justify a particular action 
(Pomerantz, 1986) such as adherent or non-adherent behavior. 
Although naturally occurring talk is preferred to interviews as the optimal way to consider 
language in use, McAvoy (2016, p.103) has argued that interviews reproduce culturally 
available discursive resources for making sense of particular meaning-making moments. 
Interviews provide a way for researchers to enquire purposely about a particular topic, such 
as adherence to nebulizer treatments, whilst allowing talk about forgetting to emerge more 
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naturally during speech, therefore enabling the researcher to examine the function that it 
serves. Discursive psychology is also interested in how credibility is maintained during talk. 
In terms of adherence, this includes the moral aspects of adherence behavior - that there is a 
common understanding that patients should be adhering to treatment - and thus how talking 
about non-adherence potentially creates the need to address moral judgements and normative 
expectations about adherent and non-adherent behavior (Bergmann, 1998). Attending to the 
discursive strategies that speakers utilize to construct their accounts, and particularly the 
differences between high and low adherers, could enable the functions that forgetting talk 
served to be made more visible; in particular, how speakers use forgetting talk to justify non-
adherence including avoidance of accepting responsibility for their non-adherence. 
Methods
We undertook the research reported here as part of a larger study - the Adherence to nebulizer 
treatments in adults with Cystic Fibrosis (ACtiF) study. ACtiF is a five-year program to 
develop and evaluate a theory-based complex intervention to improve nebulizer adherence in 
adults with cystic fibrosis. The qualitative interview study reported in this paper was 
undertaken at the beginning of the ACtiF program, as the first step in developing an 
intervention to improve nebulizer adherence, by understanding the barriers and facilitators to 
nebulizer adherence in adults with Cystic Fibrosis (Arden et al., 2019). For more information 
about the intervention and pilot feasibility study please also see Hind et al. (2019).  
Participants
We recruited adults with cystic fibrosis (defined as aged 16 and over) from a hospital-based 
cystic fibrosis center in the North of the United Kingdom. We used purposive sampling to 
approach adults with different objectively measured adherence levels. We also maximized 
diversity within the sample by approaching adults of different genders, ages, and socio-
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economic backgrounds. We approached 21 adults for interview, from which 20 consented 
and 18 were interviewed. Participants were mostly male, and well distributed across age 
groups, adherence levels, and social deprivation quintiles, with the exception of a lack of 
participants from highly affluent areas. Table 1 describes participant characteristics and levels 
of objective adherence. All participants were White British, which is representative of the 
cystic fibrosis population in the UK. Most participants had been diagnosed with cystic 
fibrosis at birth or shortly after, although two participants had been diagnosed during 
childhood, and two as adults. Twelve participants were single and three had children. Nine 
participants worked or studied full-time, two worked or studied part-time, four were not 
working and three had caring responsibilities. 
Interviews
We obtained ethical approval from the NHS REC Committee South Central - Hampshire A 
(14/SC/1455). I (Sarah) arranged and conducted all interviews. I invited participants by letter 
or email, followed up by a telephone call or emails allowing further discussion before 
deciding whether to take part. We obtained written informed consent from all participants 
including that objective adherence data would be discussed during the interview. We 
conducted interviews between April and August 2015, which took place in participants 
homes or the hospital-based unit depending on their preference. 
Each interview followed the same format using a topic guide to help cover all aspects of 
nebulizer adherence, but leaving the interview open so that the participant could describe 
their own approach to adherence. I started interviews by asking participants general questions 
about living with cystic fibrosis and undertaking any treatments before focusing on nebulizer 
usage. I then introduced adherence graphs displaying the participants personalized nebulizer 
treatment adherence history for the previous 6 months (collected as part of routine treatment 
in the hospital in numerical form and converted to graphical information for this study) to 
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prompt discussions about times of high and low adherence behavior and what might have 
caused these (see later for details). 
I also used prompts related to the theoretical domains framework (Cane, OConnor, & 
Michie, 2012) to explore any other aspects of adherence not already covered. In this latter 
part of the interview, there were two prompts in the topic guide about forgetting: How did 
you remember to use your nebulizer? and Is using your nebulizer something that you 
always remember to do? However, talk about forgetting occurred naturally throughout the 
interviews as participants described times when they had struggled with adherence to their 
nebulizer treatments. Interviews lasted on average 99 minutes, ranging from 65 to 147 
minutes.
Objectively measured adherence
One aspect of the interview was the introduction of objective adherence data regarding 
nebulizer treatments into the interview. Adherence to nebulizers, like many other treatments, 
is usually measured via self-report - which has been shown to be inaccurate (Daniels et al., 
2011). In order to measure adherence objectively, we utilized a chipped nebulizer (I-Neb®, 
Philips Respironics) that recorded how much treatment patients had taken compared to the 
amount of medication prescribed. 
In our sample, participants were on a range of nebulized treatments. All were on at least one 
mucolytic treatment to clear mucous, with most having at least a further two or three 
preventative antibiotics.  A minority of patients were on a separate bronchodilator because 
most patients mixed this with their antibiotic treatment. The number of daily treatments did 
not relate to the objective adherence level of our participants as the two lowest adherers had 
only one daily treatment, and the two highest adherers were taking between two and four 
daily treatments. 
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Objective adherence was categorized into high *P,?/% moderate (50.1-79%), low (25.1-
50%) or very low *Q+-?/ adherence in the previous six months. This was based on prior 
research that has linked high adherence *P,?/ to better health outcomes, when compared 
with low adherence (<50%) (Eakin et al., 2011). Additionally, we distinguished between very 
low and low adherence (Hoo, Campbell, Curley, & Wildman, 2017). Adherence data was 
transformed into graphs of adherence in three formats: overall adherence over the last six 
months, days of the week (whereby adherence for each day for the last six months was 
shown), and time of day (where adherence data was shown in two-hour slots), this was done 
in order to help participants identify patterns in their adherence.
Transcription and analysis
Interviews were digitally audio-recorded and transcribed verbatim. Maddy and I analyzed the 
data using framework analysis (Ritchie & Spencer, 1994) to describe facilitators and barriers 
to adherence; this is reported in a separate paper (Arden et al., 2019). During this analysis, I 
(Sarah) was struck by how both high and low adherers talked about forgetting, and that it 
seemed to be fulfilling a function within the discussion of adherence. Therefore, I carried out 
a further discursive analysis on transcript extracts where participants spoke about forgetting 
as a reason for not doing treatments or having problems remembering their nebulizer 
treatments, including talk about use of reminders and other cues and prompts. 
I re-transcribed these extracts using a modified Jeffersonian transcription system.i These new 
transcripts were read and re-read and I applied the following questions: 1) How did 
participants describe and explain forgetting behavior? 2) What functions did these 
descriptions of forgetting behavior fulfil within this interaction? 3) Did individuals in 
different adherence categories use forgetting in different ways to explain non-adherence? 
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I paid attention to patterns of language and aspects of speech such as grammar and word 
choice including interactional difficulties signaled by: hedging with pauses (Jefferson, 1989); 
hesitations and repetitions (Buttny, 1993); extreme case formulation (Pomerantz, 1986); lists 
of three parts (Jefferson, 1990), which are used to legitimize claims. I also considered 
modality, which is achieved by using tenses of verbs or adverb; for example may / might, 
could and sometimes offer less commitment to the truth than is, has or always (Fairclough, 
2003). 
In discussion with Alicia, we noticed patterns in how forgetting was presented by participants 
with different adherence levels and how this enabled them to avoid talking about other 
reasons for non-adherence. I used adherence levels to organize the discursive analysis. I then 
presented analysis of extracts to Alicia; these were discussed in depth, and she challenged my 
interpretation and analysis in terms of clarity and patterns of speech. A draft of the findings 
was circulated to the other authors, including a patient representative, for further challenge 
and refinement. 
Results
In the results, participants are given a number depending on their adherence level, from the 
lowest (1) to the highest (18) adherence. Conventionally, discursive analysis would present 
line-by-line analysis. However, due to the limitations of space, and the range of different 
ways in which participants used forgetting during adherence talk, we present less detail in 
order to show examples of each theme. 
In the extracts, I refers to me (Sarah) as the interviewer and p to the participant. The 
sample of extracts presented represents the range of functions forgetting served within the 
interactions in the 18 interviews. In this analysis, we do not in any way want to suggest that 
patients were deliberately trying to deceive about their adherence. Adherence is behaviorally 
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complex, and there are many reasons why individuals do not adhere, some of which remain 
unknown to them. However, in talking about adherence and non-adherence, patients are 
required to negotiate these underlying moral issues and we believe it is important to explore 
how this happens in conversations about adherence.
Overview of forgetting themes to justify non-adherence
Fourteen of our eighteen participants cited forgetting as a reason for non-adherence to 
nebulizer treatments. Of 18 participants, all but the lowest adherer talked about using 
different types of reminders to do treatment. We found some interesting ways in which 
forgetting was utilized by participants. In light of the moral issues identified in the 
introduction, we recognize that non-adherence was at times difficult for participants to 
acknowledge. Therefore, we have used the term admit to show how participants had to 
overcome moral issues during the interviews. We present instances where participants 
admitted non-adherence, times when they occasionally forgot their treatment, strategies to 
normalize non-adherence, and how well reminders worked to help them remember to do their 
treatment. 
A summary of themes regarding how participants constructed forgetting by adherence level is 
presented in Table 2. A discussion of each theme with example quotes is presented below.
Table 2: A summary of themes by adherence level
Number of participants by 
adherence level
Constructions of forgetting
Very Low
N=5
Low
N=5
Moderate
N=4
High
N=4
Admitting non-adherence 1 0 1 1
Occasional lapse in automaticity 0 0 0 3
Temporary lapse in memory 0 0 2 4
Struggling to admit non-adherence 1 1 0 0
Strategies to normalize non-adherence: 
- Forgetting as humorous behavior   0 0 1 0
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- Using socially acceptable justifications for forgetting 
treatment (e.g. busyness, socializing, tiredness or 
apathy, and treatment-taking knowledge)
2 3 2 4
- Forgetting as avoidance of cystic fibrosis 3 0 0 0
- Forgetting as the binary opposite of adherence 0 2 0 0
- Forgetting as routinizing non-adherence 3 0 0 0
Admitting non-adherence
Admitting non-adherence appeared easier for those with higher adherence, with the exception 
of one participant who had zero adherence and was open about non-adherence. For example, 
a very low adherer contested the definition of intentional non-adherence I used as a 
conscious decision not to use your nebulizer, which caused interactional difficulty indicated 
by the long pauses (Jefferson, 1989). My use of conscious decision was an attempt to ask 
about intentional non-adherence in a different way. The participant questioned the meaning 
as plan not to take it anywhere and I clarified this as plans not to use it at a particular time 
because of something still suggesting intentional non-adherence but softening the statement 
slightly. However, the participant was still unable or unwilling to admit planning not to do 
their treatment, using probably forgetting to explain times of non-adherence as preferable to 
admitting (at least consciously) not to adhere to treatment:
I: are there times when youve made like a conscious decision not to use your 
nebulizer?
P: (2 secs) erm (4 secs) what like sort of plan not to take it anywhere with me? 
I: Yeah or plans not to use it at particular time because of something?
P: Not that Ive planned. Ive probably forgot (3 secs) to take it. But Ive not 
planned not to take it with me (very low adherer)
A high adherer distinguished between forgetting (not a choice) and intentional non-adherence 
(choosing to not adhere), but this required them to own up to this behavior by saying, I will 
be honest, suggesting awareness that non-adherence is not good behavior: 
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I will be honest, its werent that I forgot. I just chose not to (high adherer)
Forgetting as an occasional lapse in automaticity 
Some participants with high adherence described adherence behavior as a habit that was 
automatic or hardwired, therefore making forgetting less likely. For one high adherer, a 
reduction in prescribed treatment could feel like forgetting because their routine was so 
automatic that they felt its absence:
P: Just because its hardwired isnt it?
I: (laughs) Whatever it is, is just like-
P: If I come off these many antibiotics, from twice a day, I feel like Im forgetting 
something. You know as soon as I finish them if Im not taking them I start 
and-
I: What should I be doing?
P: Yeah                                             (high adherer)
Forgetting as a temporary lapse in memory
Participants with high adherence also constructed forgetting as a temporary lapse in memory 
corrected by taking treatment as soon as they remembered, rather than not adhering:
And if I was coming back and then going straight back out and I knew that I needed 
to take it. Then I just totally forgot. I was out and remembered (high adherer)
One participant with moderate adherence also constructed forgetting as a temporary lapse that 
they needed to fix later on. However, remembering the later treatment appeared more 
effortful than for those with higher adherence, indicated by the use of it forces you to think 
and youve gotta remember:
it forces you to think, right, now youve gotta remember to take it this afternoon 
because you forgot the mornings one (moderate adherer)
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Strategies to normalize non-adherence
Participants showed awareness of normative expectations to do treatments. This created 
difficulties in admitting to non-adherence, which then needed to be justified in a socially 
acceptable way. Forgetting was one way participants explained non-adherence and was 
utilized in a number of different ways: as humorous behavior, as a socially acceptable 
justification, as avoidance of cystic fibrosis, as the binary opposite of adherence, and as 
routinizing non-adherence. 
Forgetting as humorous behavior
In the following example we all (the interviewer, interviewee and their wife) laughed about a 
moderate adherer only taking half their treatment despite the potentially life-limiting 
consequences of this action. The participant revealed a normative understanding that they 
should adhere to treatment I should take it and that adherence is good behavior thats not 
good. When the participant used forgetting that morning to explain non-adherence, they 
laughed and the others in the room joined in. It is funny because after acknowledging that 
treatment is important, they have been found out and feel the need to explain what has gone 
wrong. Forgetting as humorous behavior helped to close down the conversation:
thats not good, Im only taking it 50 percent of the time, well 55 percent of the time 
I should take it [wife in background: you havent had it yet this morning, youve 
missed this morning ((laughs))], I forgot, yeah ((laughs)). ((All laugh)) (moderate 
adherer)
Using socially acceptable justifications for forgetting 
Both high and low adherers normalized non-adherence by suggesting that simply forgetting 
was due to a lack of routine, socializing, being too busy, being tired or apathetic, or due to 
knowledge that treatments should be taken at a number of hours after a previous treatment. At 
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times, forgetting appeared to work as both a synonym for non-adherence, and as an 
explanation for non-adherent behavior that participants did not understand. A very low 
adherer claimed that socializing led to forgetting, which allowed them to talk about 
intentional non-adherence in a more socially acceptable way, rather than talking about 
choosing to go out instead of prioritizing their treatment. The use of might suggests this is 
not a definite course of action (Fairclough, 2003); this was followed by talking about 
repairing this behavior by playing catch up the following day to persuade me that this is not 
common behavior:
sometimes, if then someone says oh lets go out you know I might then, that might 
be the time I might forget my evening one. And it just never comes back to mind until 
sort of the next day and I think oh Ive actually missed my evening dose the night 
before but then you know Im sort of trying to play catch up the next day (very low 
adherer)
Some participants constructed forgetting as being too busy to adhere. In the following extract, 
talk of forgetting and a busy life helped the participant to normalize their lack of treatment-
taking routine. This moderate adherer started this extract talking about watching a popular 
television program Britains Got Talent as just busy life. However, perhaps realizing that 
this excuse needed justifying further, they added having other things on or going out, which 
created a three-part list that gave more plausibility to the justification (Jefferson, 1990). In a 
later part of the extract, the participant mentions forgetting, in addition to a busy life or 
getting into a regime, so the listener is unclear about whether forgetting is due to a busy life 
or in addition to a busy life. The description regimented regime implies that routines offer a 
strictly controlled, unappealing alternative to non-adherence, and the listener is left unclear as 
to whether the participant is unable to establish a routine in the context of a busy life, finds 
routines unappealing or does not fully understand their non-adherence behavior: 
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Oh its just, I dont know, its just busy life, you just, wed be sat watching, I dont 
know, Britains Got Talent (.) ah I didnt take me! Ah! and thats how it goes, you 
just forget or youve, youve got other things on, or youve gone out and, so in terms 
of not doing your treatment or missing stuff its purely on a basis where youve, 
youve got a busy life or youve forgot or you cant get into a regimented (.) regime of 
taking stuff (moderate adherer)
A high adherer also admitted non-adherence by presenting a moral dilemma between two 
socially unacceptable courses of action; non-adherence (forgetting) in some situations is 
reasonable you just cant if it represents a temporary lapse that cannot be repaired without 
committing a more socially unacceptable action you are not just going to come home from 
someones birthday to do your medication:
There is just going to be times when you just cant, like it might be someones 
birthday, and you might have forgot to do it. And you are not just going to come home 
from someones birthday to do your medication (high adherer)
Forgetting as avoidance of cystic fibrosis
Some participants constructed nebulizer treatments and prompts to do treatments as unwanted 
reminders of cystic fibrosis. Forgetting worked to persuade the listener that it is unacceptable 
to expect someone to think about cystic fibrosis all of the time; therefore, it is acceptable to 
forget your treatment. This very low adherer described a period of not adhering to treatment 
by putting off treatment at different time points until they forgot to do it, indicated by it will 
completely slip my mind and I just forget to do it altogether. The use of forgetting persuades 
the listener that the non-adherent behavior is not a choice but a series of smaller decisions 
that add up to forgetting, rather than intentional non-adherence. However, I called into 
question the plausibility of this statement and the participant gives another reason for non-
adherence; that they want to be normal, more like someone my age. Adherence is thus 
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presented as a barrier to normality that justifies the intentional non-adherence in a plausible 
way:
at the minute its just like out the window. Like Ill say ah Ill do that in the 
morning. Get up in the morning, and Ill find something else to do, and it wont be til 
later on in the day and Im like oh I should have done that, oh Ill do it later when I 
get in then. Get home later and it will completely slip my mind and I just forget to do 
it altogether
I-Ok, do you think thats erm, an intentional thing or?
P-I think its more like a blocking and like I put out my mind. Like I say if I block it, it 
isnt there sort of thing [yeah] its the way it is
I-How does it help you if you block it?
P-Because like, if I dont, if I block it, I dont think about it so its not there sort of 
thing I feel. So I can, I dont know how to say, not be normal, but more of someone my 
age sort of thing (very low adherer)
Forgetting as the binary opposite of adherence
A low adherer constructed adherence behavior as easy and simple; you either remember to 
do your treatment or you forget to do it. This construction normalized non-adherence making 
it harder to open up the conversation about reasons for non-adherence:
I just I either remember or I dont, its as easy, its as simple as that (low adherer)
Another low adherer constructed forgetting as the binary opposite of perfect adherence, 
which allowed the participant to normalize non-adherence because no one can be perfect all 
the time. After openly admitting to times when you dont do treatment, the explanation for 
this non-adherence was contrasted with doing treatment 100% of the time, which was 
described as idealistic, perfect behavior that is essentially unachievable. The addition of 
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never, an extreme case formulation, legitimizes never forgetting as unrealistic (Pomerantz, 
1986): 
I think there are times when you dont do them. I think you would be very err 
idealistic to just say oh yes Im perfect and I do them all the time and I never forget 
(low adherer)
Forgetting as routinizing non-adherence
Other participants with low adherence constructed many smaller instances of forgetting that 
added up to a period of low adherence in order to normalize non-adherence. In the following 
extract, the participant justified why they had not adhered whilst maintaining their identity as 
a good patient who is improving their adherence. Participants initially constructed forgetting 
as routinized examples of occasional non-adherence sometimes it can lead to sort of 
forgetting a bit more often. However, in order to maintain their identity as a good patient, the 
participant suggested that recently forgetting had become known, more conscious, and had 
improved trying to find more ideas of how to prevent the forgetfulness. Thus, they are able 
to maintain their identity as a good patient who is trying to improve their adherence in the 
context of someone who is not currently adhering: 
I think the consequences of that [missing your nebulizer] is you know sometimes it 
can lead to sort of forgetting a bit more often but I think you know the times that I 
forgot recently, Ive sort of known about it and Ive been more conscious about it and 
I think finding more ideas trying to find more ideas of how to prevent the 
forgetfulness (very low adherer)
In the following extract, the participant suggested that making smaller conscious decisions to 
put off treatment leads to forgetting, and then I forget, rather than making an intentional 
decision not to do treatment. This suggestion is made more plausible by suggesting that it is 
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an occasional disruption that only occurs at weekends to their usual regimented routine that 
the listener assumes happens during the week. It is only my knowledge of the objectively 
measured very low adherence of this participant that calls this into question:
But also on a weekend if I dont get up and were not going out theres not that 
regimented routine so I just think oh Ill do it in a bit and then a bit comes and I 
think Ill do it in a bit and it just doesnt get done and then I forget (very low 
adherer)
Using reminders to address forgetting 
Thirteen of the eighteen participants talked about currently or having in the past used some 
form of reminder to do their treatment e.g. an alarm, chart, or visual prompt such as leaving 
their nebulizer where they could see it. Of those who talked about reminders, five 
participants, four of whom had the highest adherence, described having a strong routine, 
which rendered reminders redundant. However, they did think that reminders could be useful 
at times when treatments changed, and two of them had previously used visual prompts. In 
contrast, participants with very low to moderate adherence found reminders had limited 
usefulness, actively ignored alarms on phones, and described them as nagging (low adherer) 
or annoying: 
my psychiatrist once mentioned [reminders], tried that and set alarms on my phone.  
And my phone just nearly, on a bad day, ended up through the window. Shut up 
(very low adherer)
Alternatively, reminders were just another thing to be forgotten:
but thats just something else to remember to tick [] and I always forgot to do it so 
its like oh (low adherer)
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Some participants used other people, such as parents, to remind them to do their treatment, 
suggesting a lack of self-efficacy. For example, a very low adherer appeared to shift 
responsibility to their parent, signaled in the quote below by youre going to have to and 
tell me then it will remind me: 
And I said to my mum [] youre going to have to tell me dont forget your nebulizer 
you know just remind me, tell me then it will remind me to sort of keep going with 
it  (very low adherer)
Discussion 
Using a discursive psychological approach, we found that forgetting talk fulfilled discursive 
functions related to both intentional and unintentional non-adherence, rather than only the 
expected unintentional non-adherence (Gadkari & McHorney, 2012). 
Low versus high adherence
In this study, we adopted a novel approach using chipped nebulizer data to compare how talk 
about forgetting to do your treatment differed between high and low adherers. Higher 
adherers appeared to have a clearer understanding of their own behavior, creating a 
conceptual framework to explain occasional and temporary lapses of memory and routines 
that could be repaired, drawing on the common understanding that memory only fails 
occasionally and will be rectified later (Spear, 2014). 
Recent research has suggested that reminder interventions may not always be an effective 
strategy to improve adherence (e.g., Choudhry et al., 2017; Kahwati et al., 2016). We found 
that reminders were perceived as unnecessary by high adherers, perhaps due to their well-
established routines, and unhelpful and easy to ignore by lower adherers, although (visual) 
cues such as leaving equipment where it is visible seemed to be useful at least when 
establishing adherence habits. 
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Our study also adds to understanding of forgetting as a reason for non-adherence (e.g., 
Gadkari & McHorney, 2012; McHorney, 2016) by identifying how participants with very low 
adherence normalized non-adherence by routinizing smaller, occasional lapses into a longer 
period described as forgetting, rather than non-adherence. Low adherers also contrasted 
forgetting with perfect adherence to persuade the listener that some adherence behavior was 
essentially unachievable, shutting down other explanations for non-adherence behavior that 
they found difficult to explain or did not understand. 
Forgetting as a way to address moral dilemmas in admitting non-adherence
The adherence literature has moved from talking about compliance incorporating normative 
expectations about bad and good behavior, to adherence, in which the patient decides whether 
to follow adherence advice (Donovan & Blake, 1992; e.g., Horne et al., 2005). However, in 
this study both the interviewer and participants appeared to share the expectation that 
participants should adhere to treatment, that this represented good behavior, and that any non-
adherence needed to be justified. 
Admitting non-adherence potentially threatened participants identities as a good person 
(Steele, 1988), and a good patient or self-manager who takes treatments within medical 
parameters (Ellis et al., 2017). The concept of the good patient draws on Parsons (1975) 
sociological concept of the sick role in which a patient has an obligation to get better or 
become healthier (Burnham, 2014). Forgetting was one way in which participants could 
explain non-adherent behavior, whilst maintaining the identity of the patient who is doing 
what they can to get better except in situations in which it is not possible. Although more 
recently sociologists have moved away from the concept of the sick role to the patient having 
control of their treatment (Burnham, 2014; Donovan & Blake, 1992), in our study non-
adherence still needed to be addressed within verbal interactions. Thus, forgetting became a 
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discursive resource to help participants negotiate some of the moral discourses around 
adhering to treatment (Murdoch, Salter, Poland, & Cross, 2015).    
Participants with very low adherence used avoidance of thinking about having cystic fibrosis 
as a reason for forgetting. Avoidance has been identified by others as a way of coping with 
cystic fibrosis (Abbott, Dodd, Gee, & Webb, 2001), and has been associated with higher self-
esteem, lower alienation and discomfort in young adults with CF, and rated by physicians as 
an effective coping strategy (Moise, Drotar, Doershuk, & Stern, 1987). In healthcare 
consultations there is a recognized power imbalance (Joseph-Williams, Elwyn, & Edwards, 
2014). Strategies that normalize non-adherence, similar to those found in our study, could 
deflect attention away from a more challenging conversation about non-adherence, allowing 
the patient to regain some control of the interaction (Conrad, 1985; Herrera, Moncada, & 
Defey, 2017). Forgetting talk may offer patients a way to avoid addressing reasons for non-
adherence that could bring them into conflict with health professionals who advocate 
treatment adherence, whilst helping them to maintain psychological wellbeing (Arias-llorente 
et al., 2011).
Limitations
There are some limitations to this study. First, the sample was from a single center that may 
be different from other centers. This center had started to use measurement of objective 
adherence to medication within clinical consultations, and motivational interviewing to 
address non-adherence, at the time this study was undertaken. Motivational interviewing is an 
approach to interactions in which ambivalence to behavior change is explored and resolved in 
a non-confrontational manner (Rollnick & Miller, 1995). The approach of the center may 
have affected patient views of adherence by making them more positive or negative towards 
adherence, or more aware of adherence, but the interviewer had no sense in the interviews 
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that this had occurred. Additionally, MI training is not unique to this center and may occur in 
many CF centers to some extent. 
Second, participants were made aware that they would be seeing and discussing graphs of 
their adherence data as part of this interview when agreeing to participate. Knowing this may 
have encouraged participants more open to talking about non-adherence to participate but 
also created a situation in which (non-)adherence was the topic of conversation and needed to 
be justified (Murdoch et al., 2015). 
Third, the sample had more male participants than the cystic fibrosis population. We aimed to 
get a balance of males and females and do not know why this gender imbalance occurred. It 
is possible that our findings relate more to men than to women; however, all of the issues 
identified appeared in the small number of females in the study, as well as the males. 
Implications
Forgetting is often cited as a barrier to adherence in both cystic fibrosis (e.g., Abbott et al., 
2009; Bregnballe et al., 2011; Dziuban et al., 2010; George et al., 2010; Horky et al., 2014; 
Kahwati et al., 2016; Modi & Quittner, 2006; OToole et al., 2018; Owen & John, 2016; 
Plummer et al., 2008; Sawicki et al., 2014) and other chronic conditions (Gadkari & 
McHorney, 2012; Horne et al., 2005; Ingersoll & Cohen, 2008; Mills et al., 2006; Rathbone 
et al., 2017). We do not claim to have uncovered all the different ways in which forgetting is 
utilized to account for non-adherence of nebulizer treatments in CF (Morse, 2015). However, 
we found instances where low adherers used forgetting to describe intentional non-adherence, 
which has implications for research and practice. 
Several measures of subjective adherence make the assumption that forgetting is 
unintentional e.g. MARS-5 (Horne & Hankins, 2004), and MMAS (Morisky, Green, & 
Levine, 1986). Additionally, interventions to improve adherence to medication in people with 
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chronic conditions, that only classify forgetting as unintentional non-adherence, will tend to 
focus on simple solutions that bring adherence back to the forefront of patients minds, such 
as email or text reminders to take medication. This focus may lead to interventions being 
developed to help participants avoid forgetting that may not be effective (e.g., Choudhry et 
al., 2017). 
We suggest that for some types of treatment for some conditions, forgetting can mean 
intentional non-adherence (Gadkari & McHorney, 2012), therefore, more complex, 
behaviorally-orientated, psycho-social approaches to increasing adherence may be needed 
(Conn & Ruppar, 2017; Kronish & Moise, 2017; Molloy & OCarroll, 2017).
Our findings also have implications for healthcare practitioners discussing adherence to 
treatment with patients. Even when patients talk about forgetting treatment, we suggest that 
healthcare practitioners should be open to other possible explanations for non-adherence that 
patients may feel unable to express openly, or have difficulty identifying, and that there may 
be aspects other than forgetting that patients use to avoid talking about, or to justify, non-
adherence. 
Rather than relying on self-reported adherence that may be inaccurate (Daniels et al., 2011), 
the use of objective adherence data from chipped nebulizers can help to open up patient-led 
discussions about adherence behavior. This approach recognizes that both patients and staff 
may not know how much someone adheres, or understand why they do or do not adhere 
(Wegner, 2004), and that the best intentions to adhere can be unstable and easily derailed by 
contextual factors (Arden et al., 2019). It is important that conversations about adherence are 
approached in a non-threatening way, for example, using a motivational interviewing 
approach (Rollnick & Miller, 1995). Aspects of motivational interviewing can be used as an 
accompaniment to other behavior change strategies (Kahwati et al., 2016), that take a more 
complex, theory-driven approach to help patients address difficult behavioral change by 
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addressing aspects such as habit formation (Conn & Ruppar, 2017), emotions, and 
relationships (OToole et al., 2018). 
Conclusions
A discursive psychological approach found differences between how high and low adherers 
of CF nebulizer treatments used forgetting to justify non-adherence to nebulizer treatments. 
Forgetting is usually understood as unintentional non-adherence. However, forgetting became 
a discursive resource to help participants negotiate some of the moral discourses around 
adhering to treatment.    
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i Transcription notation
Notation Description
Word. A completing intonation (not necessarily a grammatical full stop)
Word, A continuing intonation
Word Emphasis by the speaker on a word or part of a word
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Wo- Abrupt termination or word or sound
Wod Letters omitted from words or phrases
Word Reported speech
(.) Brief pause in the flow of speech
(2 secs) Longer pause, showing the time in seconds of the pause
Dont you [mm] I mean Bold text in square brackets show interviewer speech which did not break the flow 
of the interview
((interviewee laughs)) Text in double parentheses and italicized refers to notes about how something was 
said or to something that happened during the interview
[] Omitted speech
[text] Clarificatory information from transcription
() Inaudible speech
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Table 1: Characteristics of interview participants
Characteristic Group (no of participants in sample)
Gender Male (13)                      Female (5)
Age, in years 16-18(a) (4)
20-25 
26-30 (8) 
31-39 (4) 
40 and over (2)
Marital status Single (12)         Married or co-habiting (6)
Index of Multiple Deprivation quintile(b) 1 (0) most affluent 
2 (4) 
3 (5) 
4 (7) 
5 (2) most deprived
Mean objective adherence over the previous 
six months(c)
Zero or very low (5) 
Low (5) 
Moderate (4) 
High (4)
a) Patients transition from the paediatric to adult CF service from the age of 16 so are considered adult for the purposes of 
this study.
b) Index of Multiple Deprivation by postcode (Ministry of Housing Communities & Local Government, 2015). The Index 
measures relative deprivation by UK postal code stratifying into 5 quintiles where 1 is the most affluent and 5 is the most 
deprived. By entering a postal code it is possible to get an indication of the deprivation level where an individual lives.
c) Mean unadjusted objective adherence over previous six months measured from chipped i-neb nebulisers: High ;"%< 
moderate (50.1-79%), low (25.1-50%), very low =$< (Eakin et al., 2011; Hoo, Campbell, Curley, & Wildman, 2017)
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